Hennion & Walsh Asset Management Inc. Has $1.83 Million Stock Position in Danaher Co. (NYSE:DHR)

Hennion & Walsh Asset Management Inc. cut its holdings in shares of Danaher Co. (NYSE:DHR) by 44.8% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 7,337 shares of the conglomerate’s stock after selling 5,958 shares during the period. Hennion & Walsh Asset Management Inc.’s holdings in Danaher were worth $1,832,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently modified their holdings of DHR. Tsfg LLC grew its holdings in Danaher by 733.3% during the 1st quarter. Tsfg LLC now owns 100 shares of the conglomerate’s stock worth $25,000 after acquiring an additional 88 shares during the period. Cape Investment Advisory Inc. bought a new position in shares of Danaher in the 4th quarter worth $25,000. BKM Wealth Management LLC acquired a new stake in shares of Danaher during the fourth quarter worth $27,000. Wetzel Investment Advisors Inc. bought a new stake in Danaher in the fourth quarter valued at about $29,000. Finally, Rakuten Securities Inc. acquired a new position in Danaher in the fourth quarter valued at about $36,000. Institutional investors own 79.05% of the company’s stock.

Danaher Stock Down 0.7 %

Shares of Danaher stock opened at $249.85 on Friday. Danaher Co. has a 52-week low of $182.09 and a 52-week high of $269.11. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.51 and a current ratio of 1.85. The business’s 50 day simple moving average is $255.96 and its 200 day simple moving average is $246.61. The firm has a market cap of $185.06 billion, a PE ratio of 42.35, a P/E/G ratio of 3.82 and a beta of 0.85.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Tuesday, April 23rd. The conglomerate reported $1.92 EPS for the quarter, topping analysts’ consensus estimates of $1.72 by $0.20. The business had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.62 billion. Danaher had a net margin of 16.78% and a return on equity of 11.43%. The firm’s revenue for the quarter was down 2.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.36 earnings per share. On average, analysts predict that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be issued a $0.27 dividend. This represents a $1.08 annualized dividend and a dividend yield of 0.43%. The ex-dividend date is Friday, June 28th. Danaher’s payout ratio is 18.31%.

Insider Activity at Danaher

In other Danaher news, CEO Rainer Blair sold 9,005 shares of the stock in a transaction on Thursday, May 16th. The shares were sold at an average price of $265.00, for a total value of $2,386,325.00. Following the completion of the sale, the chief executive officer now owns 106,990 shares in the company, valued at $28,352,350. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other news, CFO Matthew Mcgrew sold 46,377 shares of Danaher stock in a transaction on Friday, May 10th. The stock was sold at an average price of $253.05, for a total value of $11,735,699.85. Following the transaction, the chief financial officer now owns 29,407 shares in the company, valued at approximately $7,441,441.35. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Rainer Blair sold 9,005 shares of the company’s stock in a transaction on Thursday, May 16th. The stock was sold at an average price of $265.00, for a total value of $2,386,325.00. Following the sale, the chief executive officer now owns 106,990 shares of the company’s stock, valued at $28,352,350. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 148,783 shares of company stock valued at $37,536,717. 11.10% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on DHR shares. HSBC upgraded Danaher from a “hold” rating to a “buy” rating and boosted their target price for the stock from $250.00 to $280.00 in a research report on Wednesday, April 17th. Robert W. Baird upped their target price on shares of Danaher from $259.00 to $271.00 and gave the company an “outperform” rating in a research note on Wednesday, April 24th. StockNews.com cut shares of Danaher from a “buy” rating to a “hold” rating in a research report on Tuesday, June 25th. Jefferies Financial Group assumed coverage on shares of Danaher in a research report on Monday, June 3rd. They issued a “buy” rating and a $295.00 price objective for the company. Finally, Barclays lifted their target price on Danaher from $260.00 to $270.00 and gave the stock an “equal weight” rating in a report on Wednesday, April 24th. Six investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $269.29.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.